Arlington Trust’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.6K Buy
44
+28
+175% +$13.2K ﹤0.01% 388
2026
Q1
$6.34K Buy
16
+3
+23% +$1.36K ﹤0.01% 497
2025
Q4
$6.11K Sell
13
-107
-89% -$47.5K ﹤0.01% 364
2025
Q3
$59.2K Buy
120
+5
+4% +$2.83K 0.01% 339
2025
Q2
$59K Hold
115
0.01% 336
2025
Q1
$49.3K Sell
115
-51
-31% -$24.8K 0.01% 359
2024
Q4
$80.6K Hold
166
0.02% 293
2024
Q3
$84.1K Sell
166
-13
-7% -$6.98K 0.02% 281
2024
Q2
$107K Sell
179
-107
-37% -$60.5K 0.03% 245
2024
Q1
$163K Sell
286
-4
-1% -$2.2K 0.04% 155
2023
Q4
$149K Buy
290
+147
+103% +$75.2K 0.04% 163
2023
Q3
$65.6K Buy
+143
New +$64K 0.03% 127

Other funds holding SNPS

Arlington Trust's SNPS Position: Q2 2026 in Review

Arlington Trust increased its Synopsys (SNPS) stake by 175% in Q2 2026, buying an estimated $13.2K and bringing the position to 44 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #388.

Arlington Trust first reported a position in SNPS in Q3 2023 and has held it in 12 quarters since. The position peaked at $163K in Q1 2024. 1,444 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • Arlington Trust held 44 shares of Synopsys worth $19.6K as of Q2 2026.
  • Arlington Trust bought 28 Synopsys shares in Q2 2026, an estimated $13.2K.
  • Synopsys made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #388 holding.
  • Arlington Trust first reported a position in Synopsys in Q3 2023 and has held it in 12 quarters since.
  • Arlington Trust's Synopsys position peaked at $163K in Q1 2024.
  • 1,444 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.